Healthcare
Tuesday, May 24, 2016
UPDATE 2-U.S. FDA panel recommends approval of Novo Nordisk diabetes drug
May 24 (Reuters) - A U.S. advisory panel on Tuesday
recommended approval of a new diabetes drug made by Novo Nordisk
A/S that combines two of its existing treatments in a
fixed-dose combination designed to be both effective and
convenient.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment